Infographic: How Big Pharma Is Scaling Beyond Pilot AI Projects

 
• By David Wild
  
Zydus Has Made Several Acquisitions In Quick Succession
AI Investment Is Accelerating Despite Broader Cost-Cutting (Shutterstock)

More from Innovation

More from Business Strategy